Literature DB >> 7601850

Purification and characterization of a 52-kilodalton immunoglobulin G-binding protein from Streptococcus suis capsular type 2.

B Serhir1, D Dubreuil, R Higgins, M Jacques.   

Abstract

We previously reported that group D streptococci exhibited immunoglobulin G (IgG)-binding activity and that a 52-kDa IgG-binding protein was present in all Streptococcus suis strains examined (B. Serhir, R. Higgins, B. Foiry, and M. Jacques, J. Gen. Microbiol. 139:2953-2958, 1993). The objective of the present study was to purify and characterize this protein. Pig IgG were immobilized through their Fab fragments to ECH-Sepharose 4B, and the protein was purified by affinity chromatography. Electron microscopy observations of the purified material showed filamentous structures with a diameter of approximately 4 nm; these structures were not observed when the material was treated with either urea or ethanolamine. Electrophoretic and Western immunoblot analyses showed that the 52-kDa protein constituted the bulk of the recovered material. This protein was stained with either Coomassie brilliant blue or silver nitrate; it reacted with a large variety of mammalian IgG, human IgG (Fc) fragments, human IgA, and other human plasma proteins. The 52-kDa protein exhibited lower IgG-binding affinities than protein A and protein G. However, it was able to compete with protein A and protein G for binding to human IgG. In addition, it bound chicken IgG with high affinity. This last property differentiated the 52-kDa protein of S. suis from the six IgG-binding proteins described to date. The 52-kDa protein displayed similar affinities for untreated and deglycosylated pig IgG. The N-terminal amino acid sequence (SIITDVYAXEVLDSXGNPTLEV) revealed no homology with any bacterial proteins in the Swiss-Prot database. Its isoelectric point of approximately 4.6 and its amino acid composition, rich in aspartic and glutamic acids, showed that it had some similarities with other IgG-binding proteins. In this report, we have purified and characterized a 52-kDa IgG-binding protein from S. suis capsular type 2. Although this protein shares some similarities with other IgG- and/or IgA-binding proteins, it is unique in reacting with chicken IgG.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7601850      PMCID: PMC177103          DOI: 10.1128/jb.177.13.3830-3836.1995

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  43 in total

1.  The nicotinic cholinergic receptor : different compositions evidenced by statistical analysis.

Authors:  F J Barrantes
Journal:  Biochem Biophys Res Commun       Date:  1975-01-20       Impact factor: 3.575

2.  Streptococcus suis infections in horses and cats.

Authors:  L A Devriese; F Haesebrouck
Journal:  Vet Rec       Date:  1992-04-25       Impact factor: 2.695

3.  Binding of IgA and/or IgG is a common property among clinical isolates of group A streptococci.

Authors:  G Lindahl; L Stenberg
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Selective colony blotting to expand bacterial surface receptors: applications to receptors for rat immunoglobulins.

Authors:  K J Reis; E J Siden; M D Boyle
Journal:  Biotechniques       Date:  1988-02       Impact factor: 1.993

6.  Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.

Authors:  M H Tao; S L Morrison
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

7.  Detection of immunoglobulin-G-binding proteins in Streptococcus suis.

Authors:  B Serhir; R Higgins; B Foiry; M Jacques
Journal:  J Gen Microbiol       Date:  1993-12

8.  Increase of capsular material thickness following in vivo growth of virulent Streptococcus suis serotype 2 strains.

Authors:  S Quessy; J D Dubreuil; M Jacques; F Malouin; R Higgins
Journal:  FEMS Microbiol Lett       Date:  1994-01-01       Impact factor: 2.742

9.  Discrimination of virulent and avirulent Streptococcus suis capsular type 2 isolates from different geographical origins.

Authors:  S Quessy; J D Dubreuil; M Caya; R Higgins
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Distribution of Streptococcus suis capsular types in Quebec and western Canada.

Authors:  R Higgins; M Gottschalk; M Beaudoin; S A Rawluk
Journal:  Can Vet J       Date:  1992-01       Impact factor: 1.008

View more
  5 in total

1.  Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs.

Authors:  Yuanyi Li; Gabriela Martinez; Marcelo Gottschalk; Sonia Lacouture; Philip Willson; J Daniel Dubreuil; Mario Jacques; Josee Harel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  The non-conserved region of MRP is involved in the virulence of Streptococcus suis serotype 2.

Authors:  Quan Li; Yang Fu; Caifeng Ma; Yanan He; Yanfei Yu; Dechao Du; Huochun Yao; Chengping Lu; Wei Zhang
Journal:  Virulence       Date:  2017-03-31       Impact factor: 5.882

Review 3.  Streptococcus suis: past and present.

Authors:  J J Staats; I Feder; O Okwumabua; M M Chengappa
Journal:  Vet Res Commun       Date:  1997-08       Impact factor: 2.459

4.  Acquisition of host plasmin activity by the Swine pathogen Streptococcus suis serotype 2.

Authors:  Marie-Claude Jobin; Julie Brassard; Sylvain Quessy; Marcelo Gottschalk; Daniel Grenier
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Identification and experimental verification of protective antigens against Streptococcus suis serotype 2 based on genome sequence analysis.

Authors:  Lina Liu; Gong Cheng; Changjun Wang; Xiuzhen Pan; Yanguang Cong; Qu Pan; Jing Wang; Feng Zheng; Fuquan Hu; Jiaqi Tang
Journal:  Curr Microbiol       Date:  2008-10-07       Impact factor: 2.188

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.